Search Results 31-40 of 16278 for Chronic Lymphocytic Leukemia

  1. Acute lymphocytic leukemia - Doctors and departments - Mayo Clinic

    Mayo Clinic doctors and researchers are studying the latest in diagnosis and treatment of acute lymphocytic leukemia. The Hematologic Malignancies Program ...

  2. Elevate CLL R/R: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia - Mayo Clinic

    This study is designed to evaluate PFS endpoint for acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia. Participation eligibility.

  3. A Study to Evaluate the Safety and Tolerability of KTE-X19 in Adults with Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma - Mayo Clinic

    ... chronic lymphocytic leukemia (r/r CLL) and Small Lymphocytic Lymphoma (r/r SLL). Participation eligibility. Participant eligibility includes age, gender ...

  4. Chronic Lymphoproliferative Disorders Group - Overview - Mayo Clinic

    Chronic lymphocytic leukemia · Hairy cell leukemia; Large granular lymphocyte disorders; Lymphocytosis; Natural killer cell leukemia; Prolymphocytic leukemia.

  5. A Study to Evaluate the Effectiveness and Safety of Panzyga in Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    Diagnosis of B-cell CLL established according to International Workshop on Chronic Lymphocytic Leukemia (iwCLL) criteria and documented within medical records.

  6. Acute lymphocytic leukemia - Care at Mayo Clinic

    Mayo Clinic hematopathologists use the latest in laboratory testing to provide you with an accurate diagnosis. Specialized tests can analyze leukemia cells ...

  7. Acute Lymphocytic Leukemia Clinical Trials - Mayo Clinic Research

    This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come ...

  8. Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion - Mayo Clinic

    ... chronic lymphocytic leukemia (CLL) with 17p deletion. An increased rate of deaths and serious adverse events (SAEs) among participants with front-line CLL ...

  9. A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) - Mayo Clinic

    ... Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL). Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating ...

  10. A Study to Evaluate Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    ... chronic lymphocytic leukemia. Ibrutinib may stop the growth of cancer cells ... Giving ibrutinib and obinutuzumab with venetoclax may work better at treating ...